June 17, 2026

FTC Sues WPath Over Alleged Misleading Claims on Youth Gender Treatments

The FTC and four states accuse WPath of making deceptive claims about the safety and effectiveness of puberty blockers, cross-sex hormones, and surgeries for minors.
The lawsuit claims WPath removed age-based recommendations from its care standards and promoted treatments lacking adequate evidence of safety.
WPath defends its guidelines as individualized and argues that the lawsuit is part of a government campaign against gender-affirming care.